NATIONAL HEALTHCARE CORP (NHC)

222.70 +0.20% (+0.44)

Over 5Y: +248.4%

2026-08-28
100 200
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '25 — Revenue: 371M Q3 '25 — Operating Cash Flow: 66.2M Q3 '25 — Free Cash Flow: 56.5M Q3 '25 — Net Income: 39.2M Q4 '25 — Revenue: 373.7M Q4 '25 — Operating Cash Flow: 16.8M Q4 '25 — Free Cash Flow: 6.4M Q4 '25 — Net Income: 24.8M Q1 '26 — Revenue: 369.8M Q1 '26 — Operating Cash Flow: 62.5M Q1 '26 — Free Cash Flow: 52.9M Q1 '26 — Net Income: 35.9M Q2 '26 — Revenue: 378.4M Q2 '26 — Operating Cash Flow: 43.3M Q2 '26 — Free Cash Flow: 30.7M Q2 '26 — Net Income: 40.3M 0 80M 160M 240M 320M 400M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.1
SBC / sales 0.36%
OE margin 9.5%
ROIC 10.4%
Accruals -3.2%
ROA 9.1%
ROCE 11.1%
FCF margin 9.8%
OCF / EBIT 1.3×
OCF margin 12.6%
ROE 12.5%
Gross margin —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

6.3
Segment HHI 0.81 HHI
RPO / sales —
RPO growth —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

8.0
ND/EBITDA —
Cash / Debt 1.5×
Debt / Eq 0.036×
Debt payback 0.0 yr
F-score 7.9 pts
Quick ratio 1.8×
Payout 28.4%
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.5
Sales CAGR 4Y +11.1%
Sales/sh Y/Y +5.5%
EBIT CAGR +54.1%
Shares change +0.31%
EBIT Y/Y +24.1%
EPS Y/Y +33.4%
Div. growth +4.7%
EPS CAGR 4Y -3.9%
Sales Q/Q +4.1%
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.